Health
WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death – CNA
The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with COVID-19 after they failed to reduce mortality.
GENEVA: The World Health Organization (WHO) said on Saturday (Jul 4) that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospit…
Continue Reading
-
Business23 hours agoHow to build your first $10,000 ASX share portfolio
-
Noosa News20 hours agoBrisbane drivers face longer delays at level crossings as rail network expands
-
Business21 hours agoBuy these ASX shares before the rest of the market does
-
Noosa News23 hours agoMayor Frank Wilkie explains Noosa Plan changes